1 completed, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
Follow ATG: new trials by email Literature Review of ATG trials Research Report on ATG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Research Study of ATG and Rituximab in Renal Transplantation ATG, Rituximab, Tacrolimus - Renal Transplant Recipients | Early Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2011-07-25 | 2018-11-29 |
| Donor Stem Cell Transplantation for Congenital Immunodeficiencies Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG) - Inherited Immune Deficiencies | Early Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 48 | 2007-01-19 | 2021-05-11 |
National Institute of Allergy and Infectious Diseases (NIAID) (2)
United States (2)